Persistent URL of this record https://hdl.handle.net/1887/112895
In Collections
This item can be found in the following collections:
Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial
- All authors
- Schoffski, P.; Chawla, S.; Maki, R.G.; Italiano, A.; Gelderblom, H.; Choy, E.; Grignani, G.; Camargo, V.; Bauer, S.; Rha, S.Y.; Blay, J.Y.; Hohenberger, P.; D'Adamo, D.; Guo, M.; Chmielowski, B.; Cesne, A. le; Demetri, G.D.; Patel, S.R.
- Date
- 2016-04-16
- Journal
- Lancet
- Volume
- 387
- Issue
- 10028
- Pages
- 1629 - 1637